To identify multi-markers in pancreatic cancer, we used mRNA and miRNA expression data from 104 PDAC patients and 17 normal pancreatic patients, following surgery for kidney stones and non-malignant pancreatic disease at Seoul National University Hospital (SNUH) (The detailed experiment and pre-processing steps are described in [15 ]). All human subjects studies were approved by the Institutional Review Board of Seoul National University Hospital. In this dataset, mRNA and miRNA expression levels were profiled on Affymetrix (Santa Clara, CA, USA)
HuGene 1.0 ST (33,297 probes) arrays and Affymetrix
GeneChip miRNA 3.0 (25,016 probes) arrays, respectively. We used 5,617 human miRNA probes, out of 25,016 probes, on the Affymetrix
GeneChip miRNA 3.0 array.
For validation with independent datasets of selected multi-marker candidates, we collected expression datasets for PDAC (GSE32688 [23 (
link)], GSE15471 [24 (
link)], and GSE16515 [25 (
link)]), lymphoma (LP; GSE14879 [26 (
link)]), breast cancer (BC; GSE10780 [27 (
link)]), hepatocellular carcinoma (HCC; GSE6764 [28 (
link)]), and lung carcinoma (LC; GSE19188 [29 (
link)]) from the Gene Expression Omnibus (GEO) [30 (
link)]. All collected expressed data were performed using quantile normalization and RMA normalization by R package.
Kwon M.S., Kim Y., Lee S., Namkung J., Yun T., Yi S.G., Han S., Kang M., Kim S.W., Jang J.Y, & Park T. (2015). Integrative analysis of multi-omics data for identifying multi-markers for diagnosing pancreatic cancer. BMC Genomics, 16(Suppl 9), S4.